Sans Injunction, Open Season For Generic Protonix

Law360, New York (September 13, 2007, 12:00 AM EDT) -- Altana Pharma AG has lost another bulwark against competition for its hit ulcer and heartburn drug Protonix, now that the stays that went into effect in 2005 have expired and a judge has declined to block Sun Pharmaceuticals Industries Ltd. and Teva Pharmaceutical Industries Ltd. from marketing generics.

Last Thursday, Judge Jose Linares of the New Jersey district court shot down a motion the plaintiff had made on June 22 to enjoin preliminarily the defendants from marketing generic versions of delayed-release pantoprazole sodium, the active ingredient...
To view the full article, register now.